Question explored with the scientific record
Can psma pet scans show false positives
Yes, PSMA PET scans can show false positives, and the retrieved evidence documents several specific causes.
The clearest cases come from case reports. A pancreatic neuroendocrine tumor lit up on PSMA PET in a man with prostate cancer [1]. Nodular fasciitis, a benign soft-tissue mass, showed intense uptake mimicking metastasis [6]. Chronic beryllium lung disease produced PSMA-avid lymph nodes and lung opacities that were initially read as prostate cancer spread [7]. A primary lung adenocarcinoma was also PSMA-avid in a patient on surveillance after prostatectomy [8]. These are not rare hypotheticals; they are published, histologically confirmed examples.
The mechanism is straightforward. PSMA is not exclusive to prostate cancer. It is expressed on the blood vessels of many tumors and some benign conditions [2][5]. Thyroid tumors, including benign adenomas, showed PSMA positivity in a large cohort [2]. So a bright spot on a scan is a signal that something is there, but not proof of what it is.
The evidence also shows the flip side: PSMA PET can find real cancer that other tests miss. In one case, it detected a Gleason 4+4 prostate lesion when multiparametric MRI was negative [3]. Reported sensitivity for recurrence is about 77% with specificity near 99% [4], but that specificity figure comes from a review, and the case reports above show the exceptions.
The practical takeaway: a PSMA PET finding should not be treated as a final diagnosis. Any suspicious lesion, especially in an atypical location, needs histologic confirmation before it drives treatment decisions like radiation or surgery. The scan is a map, not a verdict.
My call: PSMA PET false positives are real, documented, and clinically significant; treat any positive finding as a hypothesis requiring biopsy confirmation. Confidence: high.
Sources used 8
-
Prostate-Specific Membrane Antigen (PSMA) Avid Pancreatic Neuroendocrine Tumor
This study presents a case of a 75-year-old man with a history of prostate cancer who was found to have a PSMA-avid pancreatic neuroendocrine tumor, highlighting the potential for false-positive PSMA uptake in imaging.
DOI: 10.1097/RLU.0000000000001308 -
PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
Endothelial PSMA expression in thyroid tumor vasculature is common but highly heterogeneous across tumor types, being more prevalent in RAIR/high-grade cancers and suggesting PSMA-targeted imaging/therapy potential with important pitfalls from non-thyroid PSMA expression and den…
DOI: 10.1038/s41598-017-05481-z -
68Ga-PSMA PET/MR–Positive, Histopathology-Proven Prostate Cancer in a Patient With Negative Multiparametric Prostate MRI
In a 73-year-old man with rising PSA and a negative multiparametric MRI, 68Ga-PSMA PET/MRI identified a single PSMA-positive prostate lesion, which radical prostatectomy histopathology confirmed as Gleason 4+4 prostate cancer.
DOI: 10.1097/rlu.0000000000002143 -
Artificial intelligence and imaging biomarkers for prostate radiation therapy during and after treatment
This 2021 review surveys how AI-driven analysis of quantitative MRI (qMRI) and multiparametric MRI (mpMRI) can be used to monitor prostate cancer biology and treatment response during and after radiotherapy, with emphasis on detecting locally recurrent disease, guiding salvage t…
DOI: 10.1111/1754-9485.13242 -
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
The study demonstrates that prostate-specific membrane antigen (PSMA) is present on tumor neovasculature and TNBC cells, and that radiolabeled PSMA ligands can target TNBC both in vitro and in vivo, supporting PSMA-directed endogenous radioligand therapy for triple-negative brea…
DOI: 10.1186/s13058-019-1205-1 -
68Ga-PSMA PET/MR Showing Intense PSMA Uptake in Nodular Fasciitis Mimicking Prostate Cancer Metastasis
This study presents a case of intense Ga-PSMA uptake in a soft-tissue mass diagnosed as nodular fasciitis, highlighting the need for caution in interpreting PSMA PET results in atypical lesions that may mimic prostate cancer metastasis.
DOI: 10.1097/rlu.0000000000001310 -
Prostate-Specific Membrane Antigen–Positive Manifestations of Chronic Beryllium Lung Disease
PSMA-PET/CT uptake can occur in non-prostatic disease, as shown by a prostate cancer patient whose PSMA-avid lesions were ultimately diagnosed as chronic beryllium lung disease (berylliosis) rather than metastases, confirmed by histology and BeLPT.
DOI: meta/10.1097/rlu.0000000000002323 -
Primary Lung Adenocarcinoma With 68Gallium Prostate-Specific Membrane Antigen-PET/CT Scan Avidity in a Patient on Surveillance After Prostatectomy
This case report discusses a 76-year-old patient with prostate cancer who, after prostatectomy and rising PSA levels, was found to have a primary lung adenocarcinoma detected via PSMA PET/CT scan, highlighting the importance of differentiating between prostatic lung metastases a…
DOI: 10.1016/j.clgc.2018.03.009